Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of dapagliflozin 10 mg vs Forxiga 10 mg in healthy Thai volunteers under fasting
TCTR20241120003Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dapagliflozin (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
dapagliflozin
Beyond the preview
Go deeper on TCTR20241120003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241120003.